CIPO Patents = 1

EPO Patents = 2

Forward Citations = 8

Loading Chart...

2 inventors (with patents filed for the assignee):

Xing Dai (6 out of 38 patents)

Yaolin Wang (5 out of 17 patents)

6 patents: Sort by Forward Citations

1. 12492184 - Heteroaryl compounds, preparation methods and uses thereof (2025-12-09),

2. 12187736 - Selective estrogen receptor degraders and uses thereof (2025-01-07),

3. 11969425 - Inhibitor of indoleamine-2,3-dioxygenase (IDO) (2024-04-30),

4. 11014936 - Selective estrogen receptor degraders and uses thereof (2021-05-25),

5. 10980807 - Inhibitor of indoleamine-2,3-dioxygenase (IDO) (2021-04-20),

6. 10647724 - Selective estrogen receptor degraders and uses thereof (2020-05-12),

Inventisbio LLC is a leading biopharmaceutical company specializing in drug discovery and development. With a focus on innovative solutions, they strive to address unmet medical needs and improve patient outcomes. Their team of experienced scientists and researchers work tirelessly to bring new and effective therapies to market, collaborating with partners in the industry to accelerate the drug development process.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Jan 13 2026

6 Patents

#19 in Florham Park, NJ

#1,661 in New Jersey

#43,845 in US

Florham Park, NJ, United States of America

Inventisbio LLC

Forward Citations = 8

2 inventors:

Xing Dai (6 out of 38 patents)

Yaolin Wang (5 out of 17 patents)

Please report any incorrect information to support@idiyas.com

1 patent (CIPO):

Please report any incorrect information to support@idiyas.com

2 patents (EPO):

Please report any incorrect information to support@idiyas.com